Ebola Virus - Industry Response to Disease Outbreaks Case Study, 2020 - ResearchAndMarkets.com

DUBLIN--()--The "Ebola Virus - Industry Response to Disease Outbreaks Case Study" report has been added to ResearchAndMarkets.com's offering.

When faced with an outbreak of a pathogen with no known treatments, we are forced to rely on the pharmaceutical industry to develop interventions to curb these potential disasters. This case study analyzes how the industry responded to the Ebola outbreak, and how it compares and contrasts to the current COVID-19 outbreak.

Reasons to Buy

  • Understand the global epidemiology of COVID-19
  • Obtain a snapshot of epidemiological trends to date in the top three most-affected countries
  • Access an overview of the pipeline for therapeutics and vaccines
  • Stay up to date on available efficacy data for pipeline-stage products
  • View the clinical trials landscape by across key attributes
  • Get up to speed on highlights in deal-making trends, particularly public-private partnerships
  • Monitor top trends in social media coverage

Key Topics Covered

1 Executive Summary

1.1 Report Scope

1.2 Navigate the COVID-19 Outbreak with Pharma's COVID-19 Dashboard

1.3 Monitor the COVID-19 Outbreak with Epidemiology Indicators

2 Epidemiology

2.1 Epidemiology: Snapshot as of March 25, 2020

2.2 Epidemiology: Disease Trajectory as of March 25, 2020

2.3 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in China as of March 25, 2020

2.4 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in Italy as of March 25, 2020

2.5 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in the US as of March 25, 2020

2.6 Epidemiology Forecast: United States

3 Pipeline Overview

3.1 Pipeline Therapeutics: Breakdown by Phase

3.2 Pipeline Therapeutics: Breakdown by Molecule Type

3.3 Pipeline Therapeutics: Breakdown by Type of Developer

3.4 Pipeline Therapeutics: Clinical-Stage Candidates (Phase I - III)

3.5 Pipeline Therapeutics: Preclinical-Stage Candidates

3.6 Pipeline Therapeutics: Currently Available Data

3.7 Pipeline Vaccines: Breakdown by Phase

3.8 Pipeline Vaccines: Breakdown by Developer Type

3.9 Pipeline Vaccines: Clinical and Preclinical-Stage Candidates

4 Clinical Trials

4.1 Clinical Trials: Breakdown by Phase

4.2 Clinical Trials for Therapeutics and Vaccines

4.3 Clinical Trials: Overview by Region

4.4 Clinical Trials for Therapeutics: Leading Sponsors

4.5 Clinical Trials: Leading Industry Sponsors

4.6 Trends in Trial Design

5 Deal-making Trends

6 Social Media Trends

6.1 Key Twitter Chatter

6.2 Top Trending Tweets include #Covid19 #Coronavirus #Patients #Flattenthecurve

7 Key Findings

Companies Mentioned

  • Merck
  • Regeneron CanSino
  • Johnson & Johnson
  • GlaxoSmithKline
  • Gilead

For more information about this report visit https://www.researchandmarkets.com/r/lldsx2

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900